Gregory M. Weiss, MD

Dr. Gregory Weiss reflects on what he believes are the 6 most significant advances to occur in cardiovascular medicine since 2000. His picks included statins, public awareness campaigns, and transcatheter aortic valve replacement.

Dr. Gregory Weiss offers his thoughts on the most clinically impactful studies related to COVID-19 and cardiology released in the past year from his perspective as a critical care cardiologist.

Dr. Gregory Weiss, a critical care cardiologist, reflects on the importance of American Heart Month and the biggest remaining shortcomings in the fight against cardiovascular disease.

In his most recent column, Dr. Gregory Weiss provides an overview of what clinicians have learned related to the effects of COVID-19 on the heart.

Dr. Gregory Weiss reflects on his experience receiving the Pfizer COVID-19 vaccine and his thoughts on the ongoing rollout process.

While social media and technology have allowed greater sharing of ideas and knowledge, they have also become a major source of misinformation. In this column, Dr. Weiss reflects on practicing during the age of misinformation.

Gregory Weiss, MD, a cardiovascular anesthesiologist and critical care physician, reflects on his experiences during 2020 and coping with the additional stress and responsibilities that accompany the COVID-19 pandemic.

Dr. Gregory Weiss offers perspective on a recent guideline update from the American Heart Association outlining strategies to best manage risk of cardiovascular disease in women entering menopause.

Dr. Gregory Weiss explores and gives perspective on the latest guidelines from the AHA and ACC outlining quality measures for adults with atrial fibrillation or atrial flutter

With the prevalence of diabetes continuing to grow, Gregory Weiss, MD, reflects on his experience treating patients with diabetes as a cardiologist and how recent advances have impacted cardiology.

Dr. Gregory Weiss details how the expectations of clinicians, and cardiologists specifically, has changed since he began practicing.

Dr. Gregory Weiss reflects on data related to bariatric surgery and its subsequent impact on cardiovascular health.

Gregory Weiss, MD, examines 4 studies presented at AHA Scientific Sessions 2020 comparing the cost-effectiveness of antidiabetic agents for reducing cardiovascular events.

Dr. Gregory Weiss reflects on a pair of addendums to 2019 guidance from the ACC/AHA on the primary prevention of CVD, which focus on the role of nutrition and diet in patients.

Dr. Gregory Weiss reflects on the impact of isolation and loneliness on older patients during the COVID-19 pandemic.

In a submitted column, Dr. Gregory Weiss reflects on the importance of adherence to cholesterol-lowering medications and including statins in treatment regimens.

Gregory Weiss, MD, reflects on the idea of creating a cardiometabolic subspecialty.

With September recognized as National Cholesterol Education Month, Dr. Weiss reflects on the importance of cholesterol management as part of mitigating risk of events in patients with ASCVD.

Dr. Gregory Weiss compiles thoughts and perspective on hot line trials presented at ESC Congress 2020.

A cardiologist offers his perspective on the pros and cons of virtual medical conferences as a result of the ongoing COVID-19 pandemic.

Gregory Weiss, MD, offers his perspective on a recent scientific statement from the American Heart Association underlining the importance of dietary assessments in patients seeing a cardiologist.

Dr. Gregory M. Weiss reflects on the role of wearable technology before, during, and after the COVID-19 pandemic from the perspective of a cardiologist.

Gregory M. Weiss, MD, provides an overview of the impact mental stress can have on cardiovascular health during the ongoing pandemic.

Current smokers with type 1 diabetes had higher A1c values and greater risk of microvascular complications compared with former and never smokers, according to results of a new study.

Authors of a new study found that patients who develop diabetes later in life have a higher risk of cardiovascular disease.

Is the number of CV health measures associated with similar risk reduction among patients with higher T2DM risk or lower risk? New study sheds light.

Is DiaRem or Advanced DiaRem better for predicting diabetes remission post-bariatric surgery? Authors of a recent study sought to find out. 

A new study found a strong link between high triglyceride levels and poor glucose control in T2DM patients who are taking insulin. Click through our slideshow to get more details. 

Authors of a new study found that liraglutide lowers blood pressure, but which T2DM patients benefit most and how?

Three new studies from Obesity Week 2018 highlight non-surgical weight loss strategies for obese patients.